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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) may cause prolonged outbreaks of infections in neonatal
intensive care units (NICUs). While the specific factors favouring MRSA spread on neonatal wards are not well understood,
colonized infants, their relatives, or health-care workers may all be sources for MRSA transmission. Whole-genome
sequencing may provide a new tool for elucidating transmission pathways of MRSA at a local scale.
Methods and Findings: We applied whole-genome sequencing to trace MRSA spread in a NICU and performed a case-
control study to identify risk factors for MRSA transmission. MRSA genomes had accumulated sequence variation sufficiently
fast to reflect epidemiological linkage among individual patients, between infants and their mothers, and between infants
and staff members, such that the relevance of individual nurses’ nasal MRSA colonization for prolonged transmission could
be evaluated. In addition to confirming previously reported risk factors, we identified an increased risk of transmission from
infants with as yet unknown MRSA colonisation, in contrast to known MRSA-positive infants.
Conclusions: The integration of epidemiological (temporal, spatial) and genomic data enabled the phylogenetic testing of
several hypotheses on specific MRSA transmission routes within a neonatal intensive-care unit. The pronounced risk of
transmission emanating from undetected MRSA carriers suggested that increasing the frequency or speed of
microbiological diagnostics could help to reduce transmission of MRSA.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) may cause
prolonged outbreaks of infections in neonatal intensive care units
(NICUs), which may require aggressive, multi-faceted infection
control measures [1–4]. Infants who weigh ,1,500 g at birth (very
low birth weight [VLBW] infants) are most vulnerable to serious
MRSA infections [5]. Clinical cultures have been reported to
underestimate MRSA colonization in NICUs, whereas active
surveillance cultures could detect MRSA-affected infants earlier
and thus limit nosocomial spread [6]. MRSA screening, however,
is associated with increased costs and may lead to problems related
to false-positive results and unintended consequences [7]. While
the specific factors favouring MRSA transmission on neonatal
wards are not well understood, health-care workers, other patients
cared for by the same medical personnel, and family members
including the patients’ mothers or siblings, may be sources of
MRSA colonization [8].
Genotyping of MRSA isolates has assisted investigations of
MRSA spread within and among hospitals [9,10]. A variety of
molecular methods has been applied to differentiate and track
strains of MRSA, but all these approaches provide limited
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discriminatory power at a local scale, where single variants
commonly predominate the pathogen population [9,11–13]. In
contrast, epidemiological linkage between individual patients can
be tested phylogenetically for pathogens that accumulate nucleic
acid variation over sufficiently short timescales [14–17]. While this
concept and associated analysis tools were applied to rapidly
evolving RNA viruses in the past, it was established only recently
that MRSA may constitute such ‘‘measurably evolving popula-
tions’’, suggesting that sequencing MRSA genomes may provide a
new tool to elucidate transmission chains and pathogen reservoirs
[18,19]. Two recent papers reported that MRSA whole-genome
sequencing was able to distinguish outbreak strains from unrelated
strains within the same hospital. Importantly, such sequence data
could be generated and analysed quickly enough to impact on
patient care [20,21].
Here, we demonstrate the utility of MRSA genome sequencing
to infer the transmission history of MRSA in a NICU. MRSA
genomes proved to be highly informative for supporting a case-




The study was conducted in the neonatology unit of a tertiary
care hospital in Berlin, comprising three wards with a total
capacity of 56 beds. The retrospective case-control study spanned
the period February 8th to August 31st, 2010. Screening of all
admitted infants by nasopharyngeal and perianal swabbing for
MRSA culture was performed once a week from February 8th,
2010, and twice weekly from July 21st, 2010 until the end of our
study. In addition, 166 staff members were screened by
nasopharyngeal swabbing in February and August 2010.
Because our investigation was commissioned by the local health
department (Gesundheitsamt Berlin Mitte) in accordance with
article 25 paragraph 1 of the German Infection Protection Act of
2001, and in agreement with the responsible ethical review board
(Ethics Commission Charité - Universitätsmedizin Berlin), a
formal ethical review process and approval was not required to
meet compliance with the Declaration of Helsinki, and consent
from the next of kin, caretakers, or guardians of the neonates was
not needed.
Case-control Study
To identify risk factors for MRSA transmission, we conducted a
retrospective matched case-control study. We defined a case as a
patient in the NICU in whom colonization or infection with
MRSA spa type t032 (multilocus sequence type ST22) was detected
between February 8th and August 31st, 2010. The presumptive
exposure period for MRSA transmission was from birth or one
day before the last negative swab to one day before the first
positive swab. Controls were MRSA-negative NICU patients,
matched for birth weight (+/2100 g). If more than two eligible
controls were identified from the inpatient registry, two were
randomly selected. Cases and controls were not matched by date
of admission to avoid over-matching for possible time-dependent
factors affecting an entire ward, e.g. presence of a colonized staff
member. In addition to basic data like mode of delivery, length of
hospitalisation etc. (Table 1), we compared a wide range of
exposures in the presumed exposure period of each case and in the
corresponding days of life of the controls, including type of
nutrition, antibiotics, other oral drugs, blood transfusions, gastric
tube, i.v. lines, urine catheter, type of ventilation/endotracheal
intubation, suction of airways, surgical operations, other invasive
procedures, episodes of bradycardia and physical stimulations,
incubator/warming bed, ultrasound examinations, X-rays, ECG,
hearing tests, other specialist examinations, physiotherapy, skin-to-
skin (‘kangaroo’) care, names of nursing staff and physicians caring
for patient, ward and room for each day of exposure period, body
weight on day of MRSA detection. Nursing staff and physicians
caring for each patient were identified based on duty rosters for
each day and ward. The infants-to-nurse ratio was calculated as
the average number of infants admitted to the same ward during
the exposure period divided by the average number of nurses on
duty.
We defined an infant who was considered MRSA-negative on
the basis of available test results, but who in fact was already
MRSA-positive, as ‘‘unknown MRSA-positive’’. At the time when
a positive swab result was received on the ward (on average two
days after swabbing), an infant turned to status ‘‘known MRSA-
positive’’ (Figure 1).
Descriptive statistics comprised the calculation of median and
ranges for continuous variables, and absolute numbers and
proportions for categorical variables. Comparative analyses were
performed based on Kruskal Wallis test and univariable exact
logistic regression for matched analyses. All reported p-values are
two-sided and p,0.05 was considered significant. Statistical
analyses were performed with Stata 11.0 (StataCorp LP, TX,
USA).
MRSA Genome Sequencing and Analyses
Staphylococcal colonies on agar plates were randomly selected
for analysis. Following DNA extraction, multiplexed sequencing of
genomic DNA from S. aureus isolates was performed on an
Illumina GAIIx sequencer, providing 100-fold average coverage.
Single-nucleotide polymorphisms (SNPs) were identified by
mapping paired-end sequencing reads against the genome
sequence from a related ST22 isolate [21] and subsequently
verified through dedicated PCRs and capillary sequencing. An
alignment of SNPs in the non-repetitive core genome was used to
reconstruct the isolates’ phylogeny by applying PhyML 3.0.1 and
to calculate evolutionary rates and divergence times with the
BEAST software (http://beast.bio.ed.ac.uk/) [22]. Results were
virtually independent from clock models (strict, relaxed) and tree
priors (constant population size, exponential growth, Bayesian
skyline). Phylogenetic affiliations of six additional isolates whose
genomes had not been sequenced were determined by sequencing
informative SNPs (Table S3).
Results
Study Population
By the end of the study period (August 2010), 32 neonates had
tested positive for MRSA, spa type t032 (Table S3). The attack rate
was 25% (17/68) among infants of very low birthweight (VLBW;
birthweight ,1,500 g), in contrast to 4% (32/745) among all new
admissions, yielding a relative risk of 17 (95% CI 8.1–35.5)
associated with VLBW. Five neonates (16%) showed signs of an
MRSA infection, including two cases of septicaemia, one
pneumonia and two cases of conjunctivitis. In the case-control
study, we included 23 infants who fulfilled the case definition, had
a patient record and for whom we identified at least one fitting
control (n = 37). One additional case had been included initially,
but was excluded after genome sequencing had indicated this
patient’s MRSA to be unrelated (see below). The median time
between admission and the first positive MRSA swab was 8 days
(range, 2 to 91 days). The median length of stay at the neonatology
unit (single stay) was 47 days and did not differ significantly from
Phylogenetic Tracing of MRSA Transmission
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controls (37 days). In September, staff screening identified two
health-care workers (HCW A and B) as being colonized with
MRSA, spa type t032.
Risk Factor Analysis
Risk factors for MRSA transmission are summarized in Table 2.
Most strikingly, each additional infant with the status ‘‘unknown
MRSA-positive’’ increased the odds for other patients on the same
ward to also acquire MRSA (OR = 2.5, p = 0.003). In contrast, the
presence of infants with the status ‘‘known MRSA-positive’’ was
not a risk factor (OR = 1.0, p = 0.24). Further, the number of
infants cared for by each nurse on duty (ranging from 1.2 to 4.4)
was associated with the risk of MRSA acquisition (p = 0.04), and
moreover, contact with a specific nurse (HCW A) significantly
increased the risk of MRSA acquisition (p = 0.03).
MRSA Genome Diversity
We determined genome sequences from 30 MRSA isolates
collected during the study period. These included 24 isolates from
patients initially included in the case-control study, four isolates
from two additional patients and their nasally colonized mothers,
respectively, and two isolates from colonized health-care workers
(HCW A and B; Table S3). Phylogenetic analysis on the basis of
detected SNPs indicated that 28 isolates formed a strongly
supported monophyletic clade (Figure 2, Figure S1), confirming
close epidemiological linkage between outbreak isolates. In
contrast, two isolates (10-02187, 10-02193) fell outside this clade
and were equally divergent from the predominant strain as from
each other, as well as from another ST22 isolate from the UK
(HO50960412 [21]) (.100 SNPs in binary comparisons; Figure
S1). We conclude that in addition to the predominant strain, two
independent ST22 strains were present in the neonatology unit
during the case-control study period, which had not been
recognized previously on the basis of conventional (spa) typing.
The patient with isolate 10-02193 had been included in the case-
control study initially, but was removed from the dataset once the
MRSA genome sequence had indicated it was unrelated.
Table 1. Characteristics of the cases and controls matched for weight at birth and age during exposure time.
Cases Controls
Level of significance (p-
value)#
Weight at birth (median and range) 1165 g (606–3800 g) 1256 g{ (625–3740 g) 0.91
MRSA infection{ 22% (5/23) n/a
Duration until MRSA positive (median and
range)
8 days* (2–91 days) n/a
Male gender 52% (12/23) 41% (15/37) 0.38
Birth by caesarean section 83% (19/23) 81% (29/36) 0.84
Multiples 52% (12/23) 35% (13/37) 0.15
Gestational age (median and range) 29 weeks (23–42) 32 weeks{ (24–41) 0.43
Born on-site 91% (21/23) 97% (32/33) 0.35
Length of stay (median and range) 47 days (6–103) 38 days{ (7–116) 0.61
*from birth or last negative swab to first positive.
#Kruskal Wallis, Chi2.
{as opposed to colonisation.
{In pairs with two controls, the average value of the controls was used for the calculation.
doi:10.1371/journal.pone.0054898.t001
Figure 1. Definition of MRSA-related patient status. Initially, birth or a negative swab result in the status ‘‘MRSA-negative’’. A few days later
another swab is taken, which turns out MRSA-positive. MRSA is presumed to have been acquired latest one day before the positive swab was taken,
because it takes time for the bacteria to multiply and spread from the location of transmission to the location being swabbed. Therefore, the infant’s
status is ‘‘unknown MRSA-positive’’ from one day before the positive swab until the positive result is received on the ward. Thereafter, the infant’s
status is ‘‘known MRSA-positive’’.
doi:10.1371/journal.pone.0054898.g001
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Table 2. Risk factor analysis in univariable logistic regression.
Variable Odds-Ratio and 95% CI p-value
Additional unknown MRSA-positive infant on ward 2.5 (1.26–7.99) 0.003
Contact with HCW A 9.3 (1.24-Inf) 0.03
Increase of infant-to-staff ratio by 1 unit 2.8 (1.06–9.34) 0.04
Additional unknown MRSA-positive infant in room 4.2 (0.98–197) 0.06
Peripheral venous line 0.1 (0–1.11) 0.07
Episodes of bradycardia 4.7 (0.89–47.5) 0.07
Blood transfusion 6.9 (0.72–335) 0.12
Number of X-ray treatments 0.6 (0.27–1.15) 0.16
Gastric tube 5.6 (0.62–276) 0.18
Per known MRSA-positive infant on ward 1.0 (0.97–1.13) 0.24
Number of sonographies 1.2 (0.75–1.86) 0.54
Mechanical ventilation with intubation 0.9 (0.69–1.21) 0.60
Parenteral nutrition 0.4 (0.04–3.91) 0.63
Antibiotic therapy during exposure 0.7 (0.13–3.31) 0.82
Sum of oral medications 1.1 (0.60–2.11) 0.86
Central venous line 1.4 (0.02–118) 1
Skin-to-skin (‘kangaroo’) care 0.8 (0.18–3.47) 1
Physiotherapy 1 (0.4-Inf) 1
Significant findings (5% level of confidence) and some selected variables previously reported as risk factors for MRSA transmission are shown. Ordered by statistical
significance.
doi:10.1371/journal.pone.0054898.t002
Figure 2. Maximum clade credibility tree based on BEAST analysis of MRSA genome sequences. Tips of the tree are constrained by
bacterial isolation dates, the time scale is shown at the bottom. Node support is indicated for posterior probabilities $0.9. The case-control study
period (February 8 to August 31, 2010) is indicated by grey shading. MRSA from patients (patient numbers are indicated), healthcare workers (HCW A,
HCW B) and two mothers of patients are included. Colours indicate patient positions on wards A, B, and C, respectively. Blue bars indicate 95%
Bayesian credibility intervals of bacterial divergence dates (node heights).
doi:10.1371/journal.pone.0054898.g002
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In the core genomes from 28 outbreak isolates, we identified a
total of 26 SNPs (Table S2), which were verified by PCR and
chain-termination sequencing. This limited DNA sequence
diversity resulted in a remarkably complex phylogenetic tree
(Figure S1). The root-to-tip distances of individual isolates in this
tree correlated positively with the dates of isolation (p,0.001;
Figure S2), indicating that the bulk of the observed DNA sequence
variation had accumulated during the study period, i.e. within only
seven months.
Testing Hypotheses on Transmission Pathways
We exploited MRSA genome variation to test several hypoth-
eses about potential MRSA transmission events, which had been
provided through our epidemiological investigation:
(1) Because of the close contact between neonates and their
mothers, transmission between them was presumed in two
cases, where both had tested positive for MRSA t032 (Table
S3).
In the first case, MRSA genomes recovered from infant
and mother were fully identical, confirming the epidemio-
logical linkage (isolates 10-02172, 10-02737; Figure S1). In
the second case, however, the MRSA from the infant (10-
02187) was unrelated to the predominant strain and clearly
disparate from her mother’s isolate (10-02739), indicating
that a transmission between mother and infant had not
occurred (Figure S1).
(2) Among 160 staff members tested, contact with healthcare
worker HCW A was identified as a risk factor for MRSA
acquisition (Table 2). Consequently, colonisation of this
person with MRSA spa type t032 suggested her nasal
staphylococcal flora as a source for repeated transmission to
multiple patients.
Isolate 10-02735, which was recovered from HCW A on
2nd September 2010, descends from a basal position within
clade 1 of the phylogenetic tree (Figure S1), and according to
our coalescence-based analysis the most recent common
ancestor of 10-02735 and other isolates in clade 1 dates back
to 9th January 2010 (95% confidence interval, 17th
September 2009 to 27th February 2010; Figure 2). Since
then, 10-02735 has accumulated four point mutations that
were not found in any patient isolates (Table S2), and, in
turn, patient isolates in clade 1 carry one to eleven additional
mutations that were not found in 10-02735. Hence, the
MRSA colonising this healthcare worker has evolved
independently from the patients’ colonising strains since
approximately January 2010, and MRSA genomes provide
no evidence of reciprocal exchange between patients and
staff since then.
(3) By integrating epidemiological (temporal, spatial) and genetic
data, it was possible to reconstruct probable transmission
chains that are represented by MRSA isolates in phylogenetic
clade 1 and clade 2, respectively (Figure 2).
Based on the relative timing of MRSA detection in the
different patients and their spatial proximity alone, patient
19 could have acquired the MRSA (isolate 10-02176) in June
2010 from patients 9 or 14 (who at the time were in a
different room on ward B; Figure 2, Figure S3) or from
patients 18 or 13 (on ward A; Figure 2, Figure S3). However,
MRSA isolates from these patients are affiliated with
different clades in the phylogenetic tree (Figure 2,
Table S1) and, consequently, the most recent common
ancestor shared with 10-02176 from patient 19 dates back
almost one year (95% confidence interval, 23rd February
2009 to 3rd January 2010; Figure 2). Hence, they can be
ruled out as sources for direct transmission to patient 19
based on phylogeny, which rather suggests 10-02179 (patient
16) and 10-02736 (HCW B) as ancestors of 10-02176
(Figure 2). Twenty-eight days had passed between positive
MRSA tests for patients 16 and 19 (Figure S3), making direct
transmission between the two patients unlikely. However,
both epidemiology and phylogeny are consistent with a
scenario, where nasally colonized healthcare worker HCW
B, from which isolate 10-02736 was recovered in September
(Table S3), may have contracted the MRSA from patient 16
and served as a vector for transmission to patient 19. The
phylogenetic position and divergence time of isolate 10-
02736 indicates that HCW B had been colonized with
MRSA already in May (95% confidence interval, 31st March
to 28th May 2010; Figure 2), when otherwise there were no
closely related MRSA on the ward.
On the basis of temporal and spatial data, it is likely that the
MRSA was subsequently transmitted from patient 19 to patient 20
(who was in the same room when turning MRSA-positive) and to
patient 29 (in a different room), from where it was then passed on
to patient 31 (who shared a room with patient 29). While MRSA-
colonized, patient 31 was transferred to Ward C (Figure S3), and
his MRSA apparently got transmitted to patient 32 (who was in a
different room on Ward C). This scenario is consistent with
genome sequences from the respective isolates, which are fully
identical except for three mutations in the genome from isolate 10-
02165, whose neonate host (patient 29) had developed bacteremia
(Figure 2; Table S2).
Clade 1 in the phylogenetic tree (Figure 2) seems to represent
another transmission chain, even though the precise series of
events is less clear in this case. Isolates 10-02177 and 10-02178,
whose genomes are identical, are from patients 17 and 18 in the
same room, suggesting transmission. Additional patients succes-
sively acquired MRSA when they were on Ward B together with
colonized patients 17 and 18 (Figure S3), yielding closely related
MRSA isolates (10-02169, 10-02161, 10-02163, 10-02166, 10-
02168, 10-02170, 10-02171) (Figure 2, Figure S1), again
suggesting repeated transmission events.
Discussion
Risk Factors for MRSA Transmission
Our study identified a number of risk factors for MRSA
transmission, of which very low infant birth weight [1,6,23] and
understaffing [24] had been reported previously. In addition,
however, we detected an increased risk of transmission from
‘‘unknown MRSA-positive’’ infants on ward, but not from ‘‘known
MRSA-positive’’ infants (Table 2). The strong association of
‘‘unknown MRSA-positive’’ patients with transmission of MRSA
was further underscored by a dose-response relationship, hinting
at a causal effect. To our knowledge, the definition of the status
‘‘unknown MRSA-positive’’ is a new concept. It is based on the
delay from taking a swab to receiving the result on the ward -
usually two days in our case. During this period, an infant who
turned out later to be MRSA-positive posed the highest risk to
others. This is a plausible finding because known MRSA-positive
infants were cared for as a separate cohort, while new patients with
unknown MRSA status were treated together with MRSA-
negative infants. This result suggests that shortening the time
Phylogenetic Tracing of MRSA Transmission
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span between swabbing and receiving bacteriological results may
help to reduce cross infections with MRSA in settings where
isolation of all new admissions is not possible. It also suggests that
staff complied with hygiene standards better when dealing with a
known MRSA-positive infant.
Healthcare workers colonized with MRSA may constitute a
source for nosocomial infections [25,26]. In our study, two
healthcare workers tested positive for MRSA t032, and one of
them (HCW A) was associated with an increased risk for MRSA
transmission in the case-control study (the only one out of 160 staff
members tested). However, the MRSA isolate recovered from
HCW A displayed a number of genomic differences to those from
patients, making the nasal flora of this person an unlikely reservoir
for MRSA transmission during the study period (Figure 2). Hence,
the increased risk associated with HCW suggests a role in
transmitting MRSA from infant to infant. It is conceivable that
the same practices that facilitate transmission between patients
could also promote self colonization. However, it cannot be ruled
out completely that the statistical significance found is due to
chance alone. In contrast, through transfer of MRSA to a single
patient, nasal colonization in HCW B may have sustained
transmission during a period without MRSA-positive patients on
ward.
MRSA Genomes Document Transmission History
Two recent studies demonstrated that genome sequences from
sets of MRSA isolates could be generated and analysed within few
days by using the latest generation of benchtop sequencing
machines, enabling unequivocal identification of strains causing
outbreaks and of other strains that were unrelated [20,21]. In our
study, the latter result was exemplified by two isolates (10-02193,
10-02187) that were identified as being unrelated to the
predominant strain, even though they had been indistinguishable
by conventional typing (Figure S1).
Moreover, our results demonstrate that microevolution of
MRSA proceeded fast enough to mirror MRSA transmission
history within a single hospital unit, over the course of few months.
MRSA genomes had accumulated sufficient variation to test
epidemiological linkage among individual patients, between
infants and their mothers, and between patients and staff
members. Genome sequences documented likely transmission
events between patients that had shared rooms, but also between
different rooms on the same ward, supporting the case-control
study result which indicated that the risk of MRSA transmission
increased with each unknown MRSA-positive infant on the ward
(Table 2). Further, MRSA spread between wards associated with
patient transfer was detected and the relevance of individual
nurses’ nasal colonization could be evaluated.
One limitation of our study is that the diversity of MRSA within
individual hosts was not measured, as multiple isolates from single
patients or staff had not been collected. Little is known about intra-
host variation of MRSA genomes, which could potentially result in
uncertainties of transmission reconstructions. Such uncertainty will
likely be greatest when the genetic distance between isolates is
particularly small, exemplied in our study by #2 SNPs among
MRSA from infants sharing rooms.
In our sample of extremely closely related MRSA genomes,
point mutations had accumulated at 2.461026 nucleotide
substitutions per nucleotide site and year on average (95%
confidence intervals, 1.361026 to 3.661026), which is very
similar to the short-term evolutionary rates previously found for
other MRSA populations that had been collected over much wider
time spans and geographical ranges [18,19]. This rate corresponds
to approximately one mutation per genome every six weeks.
Accordingly, and due to the stochastic occurrence of mutations,
we found several genomes that were indistinguishable even though
they had been sampled from different patients up to 70 days apart
(isolates 10-02162, 10-02176). In contrast to a recent report [21],
we did not observe any hyper-mutators. However, both isolates
sampled from bacteremia (10-02165, 10-02169) sat at conspicu-
ously long branches in the phylogenetic tree (Figure S1), each
caused by two or three unique mutations, respectively. This
preliminary result suggests that MRSA evolution may accelerate
during bloodstream infection, which was proposed only recently
[27], and warrants systematic investigation.
Taken together, MRSA genome sequencing proved a powerful
tool for testing several hypotheses on specific MRSA transmission
routes within the neonatology unit. In the light of recent
advancements of sequencing technologies and rapidly declining
sequencing costs, our result opens exciting prospects for genome-
based epidemiological investigations of MRSA spread at a local
level, where conventional typing techniques commonly lack
discriminatory power due to the predominance of very few
genotypes [28,29]. Genome sequencing has proven useful for
investigating the epidemiology of other bacterial pathogens, too
[30], and has the potential to become a routine tool in clinical
bacteriology [31–33].
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